Protection of Human Subjects. The Recipient agrees to comply with protections for human subjects involved in a Project or related activities supported through the Underlying Agreement as required by the National Research Act, as amended, 42 U.S.C. § 289 et seq., and U.S. DOT regulations, “Protection of Human Subjects,” 49 C.F.R. part 11.
Protection of Human Subjects. Subpart A—General Provisions Sec. 50.1 Scope. 50.3 Definitions. Subpart B—Informed Consent of Human Subjects 50.20 General requirements for informed consent.
Protection of Human Subjects. Project does not involve human subjects. Project involves human subjects and was approved by the Institutional Review Board (IRB) on _ (Date). Federal Wide Assurance # .
Protection of Human Subjects. To assure compliance with 15 CFR Part 27 (the Common Rule for Protection of Human Subjects) and other relevant statutes, regulations and Presidential statements of Policy, Collaborator certifies that: The Research Plan does not involve human subjects within the meaning of the Common Rule, 15 CFR Part 27. The Research Plan involves human subjects within the meaning of 15 CFR Part 27, and Collaborator agrees to take all steps required by NIST to assure compliance with 15 CFR Part 27. Collaborator certifies that research involving human subjects shall not begin until an appropriate exemption or IRB review is completed and approved by NIST.
Protection of Human Subjects. CONTRACTOR shall comply with the provisions of applicable federal regulations, including but not limited to Executive Order 13627 dated September 25, 2012, which requires safeguarding the rights and welfare of human subjects who are involved in activities supported by federal program funds.
Protection of Human Subjects. (a) The Designated IRB is responsible for adopting and implementing institutional policies and procedures for protecting human subjects with respect to the Research in compliance with its FWA. The Designated IRB is authorized to review, oversee and monitor the Research Site’s compliance with the policies and procedures of the Designated IRB, relevant ethical principles, and applicable state and federal laws, regulations, guidance, and rulings relating to the protection of human subjects (collectively, the “Standards”), with respect to the Research.
Protection of Human Subjects. Subcontractor agrees that the rights and welfare of human subjects involved in any research under this Agreement shall be protected in accordance with 45 CFR Part 46 and with the Subcontractor’s current Assurance of Compliance on file with the Office for Human Research Protections (OHRP), Office of Public Health and Science (OPHS). Subcontractor further agrees to provide certification that the Institutional Review Board has reviewed and approved the procedures, which involve human subjects, in accordance with 45 CFR Part 46 and the Assurance of Compliance. Subcontractor shall bear full responsibility for the performance of all work and services involving the use of human subjects under this Agreement and shall ensure that work is conducted in a proper manner and as safely as is feasible. The Parties hereto agree that Subcontractor retains the right to control and direct the performance of all work under this Agreement. Nothing in this Agreement shall be deemed to constitute Subcontractor or any sub consortium, agent or employee of Subcontractor, or any other person, organization, institution, or group of any kind whatsoever, as the agent or employee of AstraZeneca or the Government. Subcontractor agrees that it has entered into this Agreement and will discharge its obligations, duties, and undertakings and the work pursuant thereto, whether requiring professional judgment or otherwise, as an independent consortium without imputing liability on the part of AstraZeneca or the Government for the acts of the Subcontractor or its employees. If at any time during the performance of this Agreement, AstraZeneca determines, in consultation with the OHRP, OPHS, ASH, that the Subcontractor is not in compliance with any of the requirements and/or standards stated in the paragraphs above, AstraZeneca may immediately suspend, in whole or in part, work and further payments under this Agreement until the Subcontractor corrects the noncompliance. Notice of the suspension may be communicated by telephone and confirmed in writing. If the Subcontractor fails to complete corrective action within the period of time designated in AstraZeneca’s written notice of suspension, AstraZeneca may terminate this Agreement in whole or in part.
Protection of Human Subjects a. The Contractor agrees that the rights and welfare of human subjects involved in research under this contract shall be protected in accordance with 45 CFR Part 46 and with the Contractor's current Assurance of Compliance on file with the Office for Human Research Protections (OHRP), Department of Health and Human Services. The Contractor further agrees to provide certification at least annually that the Institutional Review Board has reviewed and approved the procedures, which involve human subjects in accordance with 45 CFR Part 46 and the Assurance of Compliance.
Protection of Human Subjects. Contractor will comply with P.L. 93.348 regarding the protection of human subjects involved in research, development, and related activities supported by this award of assistance.
Protection of Human Subjects. 17.1.1 The Project Awardee agrees that the rights and welfare of human subjects involved in research under this Agreement shall be protected in accordance with 45 CFR Part 46 and with the Project Awardee’s current Assurance of Compliance on file with the Office for Human Research Protections (OHRP), Office of Public Health and Science (OPHS). The Project Awardee further agrees to provide certification that the Institutional Review Board has reviewed and approved the procedures, which involve human subjects, in accordance with 45 CFR Part 46 and the Assurance of Compliance.
